[go: up one dir, main page]

ZA200105881B - Sulphonyloxazolamines as therapeutic active ingredients. - Google Patents

Sulphonyloxazolamines as therapeutic active ingredients. Download PDF

Info

Publication number
ZA200105881B
ZA200105881B ZA200105881A ZA200105881A ZA200105881B ZA 200105881 B ZA200105881 B ZA 200105881B ZA 200105881 A ZA200105881 A ZA 200105881A ZA 200105881 A ZA200105881 A ZA 200105881A ZA 200105881 B ZA200105881 B ZA 200105881B
Authority
ZA
South Africa
Prior art keywords
compounds
oxazol
disorders
formula
benzenesulfonyl
Prior art date
Application number
ZA200105881A
Other languages
English (en)
Inventor
Hartmut Greiner
Gerd Bartoszyk
Henning Boettcher
Gerhard Barnickel
Bertram Cezanne
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA200105881B publication Critical patent/ZA200105881B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200105881A 1998-12-18 2001-07-17 Sulphonyloxazolamines as therapeutic active ingredients. ZA200105881B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19858593A DE19858593A1 (de) 1998-12-18 1998-12-18 Sulfonyloxazolamine als therapeutische Wirkstoffe

Publications (1)

Publication Number Publication Date
ZA200105881B true ZA200105881B (en) 2002-10-17

Family

ID=7891645

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200105881A ZA200105881B (en) 1998-12-18 2001-07-17 Sulphonyloxazolamines as therapeutic active ingredients.

Country Status (19)

Country Link
US (1) US6441013B1 (sk)
EP (1) EP1140875A1 (sk)
JP (1) JP2002533332A (sk)
CN (1) CN1146549C (sk)
AR (1) AR021896A1 (sk)
AU (1) AU763070B2 (sk)
BR (1) BR9916310A (sk)
CA (1) CA2356134A1 (sk)
CZ (1) CZ20012144A3 (sk)
DE (1) DE19858593A1 (sk)
HK (1) HK1043125A1 (sk)
HU (1) HUP0104834A3 (sk)
ID (1) ID29966A (sk)
NO (1) NO20012965L (sk)
PL (1) PL349393A1 (sk)
RU (1) RU2232757C2 (sk)
SK (1) SK8132001A3 (sk)
WO (1) WO2000037452A1 (sk)
ZA (1) ZA200105881B (sk)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19956791A1 (de) * 1999-11-25 2001-05-31 Merck Patent Gmbh Neue Sulfonyloxazolamine
DE10129940A1 (de) * 2001-06-13 2002-12-19 Merck Patent Gmbh Sulfonyloxazolamine als therapeutische Wirkstoffe
US6875771B2 (en) * 2002-07-26 2005-04-05 Bristol-Myers Squibb Company Pyridopyrimidine derivatives as 5-HT6 antagonists
FR2854632B1 (fr) * 2003-05-07 2005-06-17 Centre Nat Rech Scient Synthese de composes heterocycliques substitues
GB0419192D0 (en) * 2004-08-27 2004-09-29 Merck Sharp & Dohme Therapeutic agents
PT1831159E (pt) * 2004-12-21 2010-03-03 Hoffmann La Roche Derivados de tetralina e de indano e as suas utilizações
BRPI0614188A2 (pt) * 2005-07-29 2011-03-15 4Sc Ag compostos inibidores heterocìclicos de nf-kappab, uso dos mesmos e composição farmacêutica
DE102005061429A1 (de) * 2005-12-22 2007-06-28 Grünenthal GmbH Substituierte Oxazol-Derivate
US8394788B2 (en) * 2006-11-16 2013-03-12 The Regents Of The University Of California Phenylsulfoxyoxazole compound inhibitors of urea transporters
KR101174191B1 (ko) * 2007-02-02 2012-08-14 에프. 호프만-라 로슈 아게 중추 신경계 장애의 치료용 ｔａａｒ1 리간드로서 2-아미노옥사졸린
EP2121641B1 (en) * 2007-02-15 2014-09-24 F. Hoffmann-La Roche AG 2-aminooxazolines as taar1 ligands
CN102481794B (zh) 2009-12-28 2014-12-10 兄弟工业株式会社 带盒
RU2443697C1 (ru) 2010-12-21 2012-02-27 Александр Васильевич Иващенко Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения
WO2018012769A1 (ko) * 2016-07-12 2018-01-18 연세대학교 산학협력단 자가포식 향상물질 및 그 용도
KR102533605B1 (ko) * 2018-01-10 2023-05-17 주식회사 라이조테크 신규한 페닐설포닐 옥사졸 유도체 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5860396A (en) * 1995-05-19 1996-11-29 G.D. Searle & Co. Substituted oxazoles for the treatment of inflammation
NZ330464A (en) 1996-02-20 2000-04-28 Bristol Myers Squibb Co Methods for the preparation of biphenyl isoxazole sulfonamides

Also Published As

Publication number Publication date
NO20012965D0 (no) 2001-06-15
WO2000037452A1 (de) 2000-06-29
AU1861200A (en) 2000-07-12
HUP0104834A3 (en) 2005-06-28
SK8132001A3 (en) 2002-02-05
CN1146549C (zh) 2004-04-21
CZ20012144A3 (cs) 2002-01-16
EP1140875A1 (de) 2001-10-10
RU2232757C2 (ru) 2004-07-20
DE19858593A1 (de) 2000-06-21
CA2356134A1 (en) 2000-06-29
HK1043125A1 (zh) 2002-09-06
US6441013B1 (en) 2002-08-27
ID29966A (id) 2001-10-25
PL349393A1 (en) 2002-07-15
JP2002533332A (ja) 2002-10-08
NO20012965L (no) 2001-06-15
AU763070B2 (en) 2003-07-10
AR021896A1 (es) 2002-08-07
HUP0104834A2 (hu) 2002-07-29
BR9916310A (pt) 2001-11-06
CN1331684A (zh) 2002-01-16

Similar Documents

Publication Publication Date Title
US6441013B1 (en) Sulphonyloxazolamines as therapeutic active ingredients
US4279819A (en) Aminoalkyl furan derivatives
CA2382355C (en) Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
AU2014241065A1 (en) Glycosidase inhibitors
EP2459542B1 (en) Substituted N-benzyl-4,5-dihydrooxazol-2-amines useful as selective alpha 2B/2C receptor agonists
KR20220084355A (ko) 에스트로겐-관련 수용체 알파 조절제
BG60587B1 (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
WO2002100842A1 (en) Sulfonyloxazolamines and their use as 5-ht6 ligands
US6737426B1 (en) Sulfonyloxazoleamines
KR20010086457A (ko) 치료 활성 화합물로서의 술포닐옥사졸아민류
US4169855A (en) N'-derivatives of n-(2-mercapto-ethyl)-2-nitro-1,1-ethenediamine
MXPA01006230A (en) Sulphonyloxazolamines as therapeutic active ingredients
US4105795A (en) Antispasmodic substituted sulphoximides
DE69107874T2 (de) Imidazolderivate und diese Imidazolderivate als Wirkstoffe enthaltende Antiepileptika.
SK2192002A3 (en) Piperidine alcohol derivative, process for the preparation and use thereof and pharmaceutical composition comprising same
BG100331A (bg) Фармакологично активни енантиомери
TW200524600A (en) Novel arylazole derivatives, their manufacture and use as pharmaceutical agents